Pro-Dex Inc

NASDAQ PDEX

Download Data

Pro-Dex Inc Debt to Capital Ratio for the quarter ending March 31, 2024: 0.28

Pro-Dex Inc Debt to Capital Ratio is 0.28 for the quarter ending March 31, 2024, a -14.98% change year over year. The debt to capital ratio measures the proportion of a company's total capitalization that is financed by debt. It is calculated by dividing total debt by the sum of total debt and shareholders' equity. This ratio provides insights into the capital structure and financial risk of the company. A higher ratio indicates a greater reliance on debt financing.
  • Pro-Dex Inc Debt to Capital Ratio for the quarter ending March 31, 2023 was 0.32, a -8.65% change year over year.
  • Pro-Dex Inc Debt to Capital Ratio for the quarter ending March 31, 2022 was 0.35, a -8.15% change year over year.
  • Pro-Dex Inc Debt to Capital Ratio for the quarter ending March 31, 2021 was 0.39, a 100.34% change year over year.
  • Pro-Dex Inc Debt to Capital Ratio for the quarter ending March 31, 2020 was 0.19, a -8.63% change year over year.
NASDAQ: PDEX

Pro-Dex Inc

CEO Mr. Richard Lee Van Kirk Jr.
IPO Date Aug. 18, 1995
Location United States
Headquarters 2361 McGaw Avenue, Irvine, CA, United States, 92614
Employees 145
Sector Healthcare
Industry Medical instruments & supplies
Description

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

StockViz Staff

September 19, 2024

Any question? Send us an email